tirzepatide cvot trial SURPASS-CVOT trial: was non-inferior to dulaglutide and superior to putative placebo for reducing the composite of CV death/HF events in patients with T2D and ASCVD. #AHA25 View the slides here: https://t.co/6VQpBHFP2I Effect of tirzepatide versus insulin

1866-485-7979.

The study sponsor was involved in several aspects of the research, including the study design, the interpretation of data, the writing of the manuscript, and the decision to submit the manuscript for publication

Guide to Mini Gastric Sleeve Surgery vs Gastric Sleeve Surgery

There is increasing interest in whether and how GLP-1 medicines impact adipose tissue, muscle, and bone, questions with important clinical implications, especially in individuals who may be frail and experiencing rapid and substantial weight loss

Heres a glimpse of what I discuss: - The mechanisms behind GLP-1 agonists' ability to promote weight loss - New data on body weight changes after discontinuing the drug - Effects of GLP-1 agonists on lean mass and body composition, and the role of protein and resistance training in preserving muscle - Early indications that GLP-1 agonists may help treat substance abuse disorders - More